Acumen Pharmaceuticals, Inc.
ABOS
Rank in Stocks
#27023
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the... Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.
Share Price
$0.237
Last synced: 2026-11-09
Market Cap
$17.14M
Change (1 day)
6.04%
Change (1 year)
-87.97%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Acumen Pharmaceuticals, Inc. (ABOS)
Category
Healthcare
EPS for Acumen Pharmaceuticals, Inc. (ABOS)
EPS as of September 2026 TTM: $-1.55
According to Acumen Pharmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is $-1.55. At the end of 2025 the company had an EPS of $-2.00, a decrease compared to its 2024 EPS of $-1.71.
EPS history for Acumen Pharmaceuticals, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.55 | -22.50% |
| 2025 | $-2.00 | 16.96% |
| 2024 | $-1.71 | 58.33% |
| 2023 | $-1.08 | 1.89% |
| 2022 | $-1.06 | -59.70% |
| 2021 | $-2.63 | 911.54% |
| 2020 | $-0.26 | 30.00% |
| 2019 | $-0.20 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,110.32% |
US
|
|
| $-7.07 | 356.13% |
US
|
|
| $-5.29 | 241.29% |
AU
|
|
| $12.88 | -930.97% |
BE
|
|
| $21.56 | -1,490.97% |
NL
|
Questions about Acumen Pharmaceuticals, Inc.'s earnings per share (EPS)
What is Acumen Pharmaceuticals, Inc.'s earnings per share (EPS)?
Acumen Pharmaceuticals, Inc.'s earnings per share (EPS) over the last twelve months is $-1.55, as of Sep 2026.
What was Acumen Pharmaceuticals, Inc.'s earnings per share (EPS) in 2025?
In 2025, Acumen Pharmaceuticals, Inc.'s earnings per share (EPS) was $-2.00, compared with $-1.71 in 2024.
How has Acumen Pharmaceuticals, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Acumen Pharmaceuticals, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.26) and lowest in 2021 ($-2.63).
How does Acumen Pharmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
Acumen Pharmaceuticals, Inc.'s earnings per share (EPS) ($-1.55) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.